Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Elizabeth Rula, executive director of the ACR-backed research outfit, discusses how to solve staffing shortages, prior authorization issues, and other key issues facing radiology.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
The COlorectal Cancer detection with AI, or COCA, model is a cost-effective, scalable solution that turns routine CT scans into opportunistic exams that can be used to proactively identify CRC.
Reactive axillary lymph nodes seen on screening mammograms after vaccination can last for many months and should not be cause for imaging delays, experts reported in Radiology.
After surgical excision, 10.2% of the architectural distortion cases with nonmalignant pathology at biopsy were upgraded to malignant, researchers reported in the American Journal of Roentgenology.
After witnessing a 6-fold increase in early-stage cancer diagnoses and no change in late-stage disease numbers, experts began to question ongoing screening methods.